David Carballo

7.1k total citations
85 papers, 1.4k citations indexed

About

David Carballo is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, David Carballo has authored 85 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Cardiology and Cardiovascular Medicine, 26 papers in Surgery and 13 papers in Epidemiology. Recurrent topics in David Carballo's work include Acute Myocardial Infarction Research (20 papers), Lipoproteins and Cardiovascular Health (18 papers) and Heart Failure Treatment and Management (12 papers). David Carballo is often cited by papers focused on Acute Myocardial Infarction Research (20 papers), Lipoproteins and Cardiovascular Health (18 papers) and Heart Failure Treatment and Management (12 papers). David Carballo collaborates with scholars based in Switzerland, United States and United Kingdom. David Carballo's co-authors include François Mach, Martine Louis‐Simonet, Sebastian Carballo, Slim Slama, François Sarasin, Nicole Probst‐Hensch, Arnold von Eckardstein, David Nanchen, Bariş Gencer and Martin Adam and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

David Carballo

76 papers receiving 1.3k citations

Peers

David Carballo
Nico Dragano Germany
I. Ford United Kingdom
Parveen K. Garg United States
Jeffrey M. Saland United States
Quan Huynh Australia
Michael E. Mussolino United States
M. L. Bots Netherlands
Nico Dragano Germany
David Carballo
Citations per year, relative to David Carballo David Carballo (= 1×) peers Nico Dragano

Countries citing papers authored by David Carballo

Since Specialization
Citations

This map shows the geographic impact of David Carballo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Carballo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Carballo more than expected).

Fields of papers citing papers by David Carballo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Carballo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Carballo. The network helps show where David Carballo may publish in the future.

Co-authorship network of co-authors of David Carballo

This figure shows the co-authorship network connecting the top 25 collaborators of David Carballo. A scholar is included among the top collaborators of David Carballo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Carballo. David Carballo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hageman, Steven H J, Stephen Kaptoge, Lisa Pennells, et al.. (2025). Using SCORE2 with a risk chart or online calculator: impact on model performance, treatment eligibility, and cardiovascular disease prevention. European Heart Journal - Quality of Care and Clinical Outcomes. 12(2). 213–220.
2.
Branca, Mattia, David Carballo, Konstantinos C. Koskinas, et al.. (2024). Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromes. SHILAP Revista de lepidopterología. 58. 1–8.
3.
Klingenberg, Roland, Soheila Aghlmandi, Lorenz Räber, et al.. (2021). Cysteine‐Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes. Journal of the American Heart Association. 10(20). e020488–e020488. 5 indexed citations
4.
Nanchen, David, David Carballo, Stefan Bilz, et al.. (2021). Effectiveness, Adherence, and Safety of Evolocumab in a Swiss Multicenter Prospective Observational Study. Advances in Therapy. 39(1). 504–517. 10 indexed citations
5.
Tessitore, Elena, Sandra Handgraaf, Antoine Poncet, et al.. (2021). Symptoms and quality of life at 1-year follow up of patients discharged after an acute COVID-19 episode. Swiss Medical Weekly. 151(4950). w30093–w30093. 15 indexed citations
6.
Carballo, David, et al.. (2020). Eligibility for Sacubitril–Valsartan in Patients with Acute Decompensated Heart Failure. ESC Heart Failure. 7(3). 1282–1290. 9 indexed citations
7.
Negro, Alessandro, et al.. (2019). Congenital left ventricular diverticulum in an asymptomatic patient: multi-modal evaluation. Cardiovascular Medicine.
8.
Carballo, David, Nicolas Rodondi, Reto Auer, et al.. (2019). Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention. PLoS ONE. 14(2). e0211464–e0211464. 5 indexed citations
9.
Nanchen, David, Roland Klingenberg, Bariş Gencer, et al.. (2019). Inflammation during acute coronary syndromes — Risk of cardiovascular events and bleeding. International Journal of Cardiology. 287. 13–18. 20 indexed citations
10.
Carballo, David & François Mach. (2018). Intensive LDL-cholesterol lowering and inhibition of inflammation to further reduce cardiovascular risk?. Cardiovascular Medicine. 1 indexed citations
11.
Gencer, Bariş, Reto Auer, David Nanchen, et al.. (2015). Expected impact of applying new 2013 AHA/ACC cholesterol guidelines criteria on the recommended lipid target achievement after acute coronary syndromes. Atherosclerosis. 239(1). 118–124. 24 indexed citations
12.
Auer, Reto, Bariş Gencer, Lorenz Räber, et al.. (2014). Quality of Care after Acute Coronary Syndromes in a Prospective Cohort with Reasons for Non-Prescription of Recommended Medications. PLoS ONE. 9(3). e93147–e93147. 27 indexed citations
13.
Gerbase, Margaret W., Julia Dratva, J M Tschopp, et al.. (2014). Sleep fragmentation and sleep-disordered breathing in individuals living close to main roads: results from a population-based study. Sleep Medicine. 15(3). 322–328. 9 indexed citations
14.
Eze, Ikenna C., Emmanuel Schaffner, Evelyn Fischer, et al.. (2014). Long-term air pollution exposure and diabetes in a population-based Swiss cohort. Environment International. 70. 95–105. 187 indexed citations
15.
Humair, Jean‐Paul, Nicolas Garin, Eric Gerstel, et al.. (2014). Acute Respiratory and Cardiovascular Admissions after a Public Smoking Ban in Geneva, Switzerland. PLoS ONE. 9(3). e90417–e90417. 29 indexed citations
16.
Mehta, Amar, Martin Adam, Emmanuel Schaffner, et al.. (2012). Heart Rate Variability in Association with Frequent Use of Household Sprays and Scented Products in SAPALDIA. Environmental Health Perspectives. 120(7). 958–964. 18 indexed citations
17.
Adam, Martin, Denise Felber Dietrich, Emmanuel Schaffner, et al.. (2012). Long-term exposure to traffic-related PM10 and decreased heart rate variability: Is the association restricted to subjects taking ACE inhibitors?. Environment International. 48. 9–16. 16 indexed citations
18.
Carballo, David, et al.. (2011). Malignant arrhythmia associated with chest pain and a diagnosis of myocarditis. Cardiovascular Medicine. 14(1). 27–28. 1 indexed citations
19.
Carballo, Sebastian, David Carballo, Pierre‐Frédéric Keller, & Marco Roffi. (2011). Spécificités du [b]diabète[/b] dans le syndrome coronarien aigu. Revue Médicale Suisse. 7(297). 1200–1206. 1 indexed citations
20.
Sarasin, François, et al.. (2002). Prevalence of orthostatic hypotension among patients presenting with syncope in the ED. The American Journal of Emergency Medicine. 20(6). 497–501. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026